Cargando…
Identification of tumor mutations in plasma based on mutation variant frequency change (MVFC)
To overcome the dependency of strategies utilizing cell‐free DNA (cfDNA) on tissue sampling, the emergence of sequencing panels for non‐invasive mutation screening was promoted. However, cfDNA sequencing with panels still suffers from either inaccuracy or omission, and novel approaches for accuratel...
Autores principales: | Chen, Geng, Peng, Fang, Dong, Xiuqing, Cai, Zhixiong, Li, Zhenli, He, Lei, Hu, Jinpan, Deng, Xiaoxu, Guo, Yutong, Qiu, Liman, Zhou, Yang, Liu, Jingfeng, Zhang, Huqin, Liu, Xiaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483605/ https://www.ncbi.nlm.nih.gov/pubmed/37496285 http://dx.doi.org/10.1002/1878-0261.13498 |
Ejemplares similares
-
Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns
por: Li, Zhenli, et al.
Publicado: (2021) -
Circular RNA profiling identifies circADAMTS13 as a miR‐484 sponge which suppresses cell proliferation in hepatocellular carcinoma
por: Qiu, Liman, et al.
Publicado: (2019) -
Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma
por: Dong, Xiuqing, et al.
Publicado: (2022) -
Circular RNA CircEPB41L2 Functions as Tumor Suppressor in Hepatocellular Carcinoma Through Sponging miR-590-5p
por: Chen, Feng, et al.
Publicado: (2021) -
Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report
por: Zeng, Yongyi, et al.
Publicado: (2020)